Gastrointestinal Cancer News

MADRID — Adding pembrolizumab to trastuzumab and chemotherapy extended PFS for patients with unresectable HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma, study results presented at ESMO Congress showed.

MADRID — Pembrolizumab with chemotherapy before and after surgery increased pathologic complete response among patients with locally advanced gastric or gastroesophageal junction cancer, according to findings presented at ESMO Congress.

Debulking combined with standard systemic therapy did not significantly impact overall quality of life for a cohort of patients with metastatic colorectal cancer, according to study results.

Liver Cancer Awareness Month, celebrated every October, seeks to raise awareness about the third deadliest cancer in the United States, with approximately 41,000 new cases and as many as 30,000 deaths each year.

The National Academy of Medicine announced the election of 90 regular members and 10 international members.

Postdiagnosis antidepressant use reduced mortality risk among patients with hepatocellular carcinoma, according to data published in JAMA Network Open.

Information AI-powered chatbots provided related to search queries on the most common cancer types generally produced accurate information with poor actionability, study results published in JAMA Oncology showed.

In a Healio video exclusive, Rene D. Gomez-Esquivel, MD, discusses risk factors for pediatric colon cancer, as well as best practices for screening and lesion resection, from his presentation at the 2023 NASPGHAN annual meeting.

Susan Tsai, MD, has been appointed chief of the division of surgical oncology at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

ASCO released a research statement outlining new recommendations regarding the appropriate assessment of ovarian toxicity in cancer clinical trials.